Twitter | Search | |
AstraZeneca
We're a global, science-led biopharmaceutical company & our innovative medicines are used by millions of patients worldwide. We believe in what science can do.
6,181
Tweets
1,461
Following
154,135
Followers
Tweets
AstraZeneca 5h
We’re pleased to present 84 abstracts from our research at this week. Our data will highlight the exploration of new frontiers in , and DNA damage response.
Reply Retweet Like
AstraZeneca Mar 23
“We believe that significant patient benefit can be realised in China and across the world by collaborating openly across technology and healthcare,” explained Leif Johansson, our Chairman, when he attended the China Development Forum in Beijing today
Reply Retweet Like
AstraZeneca Mar 21
Cardiovascular, renal and metabolic () patients often have overlapping diseases and associated risk factors. At AstraZeneca, we continually evolve our clinical research with a goal to help advance clinical practice for preventive therapies for these patients.
Reply Retweet Like
AstraZeneca Mar 21
Disputes may be inevitable at some point during a collaboration due to the dynamic and evolving nature of the partnership. Learn how to settle differences collaboratively in the first of two articles about dispute resolution:
Reply Retweet Like
AstraZeneca Mar 21
At AstraZeneca, we are focused on improving heart health. Rodrigo Gribble, VP Cardiovascular, explains how we are working with local authorities and organisations to help HCPs close the gap between guidelines and practice to help improve patient outcomes.
Reply Retweet Like
AstraZeneca retweeted
American College of Cardiology Mar 18
WE MADE IT❣️Thank you to every single person in our ever-growing family for following, liking, and retweeting. This is an exciting milestone to reach, especially during , and we are so happy to be a part of the online 💓health conversation.
Reply Retweet Like
AstraZeneca retweeted
Dr Sam Raza Mar 17
Carrots and Cardiology
Reply Retweet Like
AstraZeneca Mar 20
How can we help improve these patient statistics? We are working closely with cardiologists and HCPs to help find new ways to potentially prevent a second heart attack including better coordination and understanding of patient risk factors.
Reply Retweet Like
AstraZeneca Mar 20
We are excited to celebrate this milestone investment to strengthen our commitment to patients, innovation and talent development in Malaysia between 2019 and 2023.
Reply Retweet Like
AstraZeneca Mar 20
A recent paper in collaboration with demonstrates how activation of AMPK in white fat tissue could guide the identification of potential new targets for obesity. Read more:
Reply Retweet Like
AstraZeneca Mar 19
Thank you to everyone who joined us at ! We look forward to advancing our research with the aim of improving care for patients living with cardiovascular, renal and metabolic diseases.
Reply Retweet Like
AstraZeneca Mar 18
Research shows that mutations can be acquired or inherited from both parents. Testing for BRCA mutations can help assess an increased risk of several cancers and help inform treatment decisions
Reply Retweet Like
AstraZeneca Mar 18
To address cardiovascular, renal and metabolic diseases, we strive to deliver transformative science that aims to improve treatment practices and health for millions of patients worldwide. Find out more about our approach:
Reply Retweet Like
AstraZeneca Mar 18
Surgical intervention (PCI) is the preferred therapy to unblock blood vessels in patients undergoing a STEMI , but many people do not have timely access to such methods. We are at to discuss our latest research. Read more here:
Reply Retweet Like
AstraZeneca Mar 17
BRCA mutations increase the risk of developing , and other cancers, in women. Our mission is to find the most effective options for these patients, with our continuous research in mutations such as .
Reply Retweet Like
AstraZeneca Mar 17
Type-2 patients may not know all the risks of complications, such as . Awareness and action are important for these patients to take care of themselves. Share this video to help people ‘Know the Danger.’
Reply Retweet Like
AstraZeneca Mar 17
Data shows that cardiovascular, renal and metabolic diseases are interlinked. To support a holistic treatment approach, we bring robust clinical trial data and real-world evidence together. Find out more:
Reply Retweet Like
AstraZeneca Mar 16
Our research programme aims to help advance future clinical practice with preventive therapies for the treatment of patients with overlapping , renal, and metabolic diseases and their associated risk factors. Find out more:
Reply Retweet Like
AstraZeneca Mar 16
In 2018, more than 295,000 women were diagnosed with . For newly-diagnosed advanced cases, the primary treatment aim is to delay disease progression and maintain quality of life, with the aim of achieving complete remission.
Reply Retweet Like
AstraZeneca Mar 16
45% of you said some/many of your patients have T2D and heart failure. HF incidence in patients with diabetes is significantly greater than in patients without. Understanding T2D risks, such as HF, is important for optimising patients’ treatment and improving outcomes.
Reply Retweet Like